Crossmark

Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab

Crossref DOI link: https://doi.org/10.1016/j.reumae.2020.07.010

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Garrido, Juan José Lerma

Pérez, Antonio Gracia

Torres, Antonio Pérez

Cid, Amalia Rueda

Almela, Clara Molina

Cubillo, María Dolores Pastor

Fernández, Cristina Campos

Trull, Isabel Balaguer

Carmona, Loreto

Catalá, Javier Calvo
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2020.07.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2020.07.010

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below